Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT04891952Not Yet Recruiting

Measuring the Impact of Onco4D® Guidance on Chemotherapy Selection and Outcomes

Role: lead

NCT03739177Unknown

Onco4D(TM) Biodynamic Chemotherapy Selection for Bladder Cancer Patients

Role: lead

NCT03164863Unknown

Onco4D(TM) Biodynamic Chemotherapy Selection for Breast Cancer Patients

Role: lead

All 3 trials loaded